Skip to main content
Clinical Trials/ISRCTN39292293
ISRCTN39292293
Completed
未知

Quality of life, physical activity and satisfaction of patients after intra-articular injection of hyaluronic acid with mobile reticulum for the treatment of chondral injury of the knee due to osteoarthritis due to overuse and/or in the conservative treatment of the meniscus injury

Centre de Tecnificació Esportiva de la Residencia Blume0 sites165 target enrollmentStarted: May 11, 2023Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
Centre de Tecnificació Esportiva de la Residencia Blume
Enrollment
165

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All

Inclusion Criteria

  • The study population comprised patients (male or female) older than 18 years seen at one of the participating clinics between December 2018 and July 2019 for their first follow\-up visit after intra\-articular injection of mobile reticulum hyaluronic acid due to:
  • 1\. Mild to moderate symptomatic knee osteoarthritis responding to clinical and radiological criteria of American College of Rheumatology (ACR) and a Kallgren and Lawrence (KL) score II/III evidenced by radiography and/or MRI. Patients received two consecutive intra\-articular injections of HYMOVIS (3 ml syringe with 8 mg of non\-cross\-linked HA alkylamida HYADD4; FIDIA Farmaceutici, Italy) given at 1\-week intervals according to the prospect.
  • 2\. Knee meniscal tear (traumatic or degenerative) objectifiable by radiography and/or MRI. Patients received two consecutive intra\-articular injections of HYMOVIS given at 2\-week intervals according to the prospect.
  • 3\. Mild to moderate symptomatic knee osteoarthritis with meniscal tear. Patients received two consecutive intra\-articular injections of HYMOVIS given at 1\-week intervals according to the prospect.

Exclusion Criteria

  • 1\. Viscosupplementation or corticosteroid therapy in the last 6 months
  • 2\. Concomitant diseases that could interfere with the tests during the data collection period or that could lead to erroneous results (i.e., rheumatoid arthritis, metabolic bone diseases, gout, Paget's disease of bone, symptomatic chondrocalcinosis)
  • 3\. Knee arthroplasty or other knee surgery in the last 12 months
  • 4\. Any scheduled surgery during the data collection period
  • 5\. Evidence or suspicion of infection in the affected joint or skin diseases of the knee, such as dermatitis or psoriasis
  • 6\. Patients with bilateral knee OA

Investigators

Sponsor
Centre de Tecnificació Esportiva de la Residencia Blume

Similar Trials